Form 8-K - Current report:
SEC Accession No. 0000950170-25-084846
Filing Date
2025-06-11
Accepted
2025-06-11 16:23:09
Documents
10
Period of Report
2025-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K krro-20250611.htm   iXBRL 8-K 79859
  Complete submission text file 0000950170-25-084846.txt   199336

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krro-20250611.xsd EX-101.SCH 32947
13 EXTRACTED XBRL INSTANCE DOCUMENT krro-20250611_htm.xml XML 4884
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 251040286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)